See also this year's filing and all EDGAR filings for this company.
PDF Report 0001938046_2025_Mangoceuticals_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.4747413073092356, 'aggregate_val': 16089573, 'exp_sum': 30631712, 'exp_to_value': {'IntangibleAssets': 14232484, 'AssetsNonCurrent': 14542139, 'AssetsCurrent': 1547434, 'PropertyPlantAndEquipment': 1794, 'remainder_Assets': 307861}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.49876742300050153, 'aggregate_val': 15370511, 'exp_sum': 30665427, 'exp_to_value': {'IntangibleAssets': 15232617, 'AssetsNonCurrent': 15294916, 'AssetsCurrent': 75595, 'PropertyPlantAndEquipment': 2806, 'remainder_Assets': 59493}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001938046, Mangoceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 15,232,617 |
| 1 | AssetsNonCurrent | 15,294,916 |
| 2 | AssetsCurrent | 75,595 |
| 3 | PropertyPlantAndEquipment | 2,806 |
| 4 | remainder_Assets | -15,235,423 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 1,425,463 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 1,063,781 |
| 9 | CostOfGoodsAndServicesSold | 93,296 |
| 10 | GeneralAndAdministrativeExpense | 3,000,571 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 1,478,663 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 2,951,555 |
| 17 | remainder_Revenues | 615,873 |
| 18 | remainder_NetIncome | -735,233 |
| 19 | remainder_ComprehensiveNetIncome | -8,764 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 15,370,511 |
| 1 | Liabilities | 1,425,463 |
| 2 | Expenses | 8,587,866 |
| 3 | Revenues | 615,873 |
| 4 | StockholdersEquity | 13,945,048 |
| 5 | NetIncome | -8,707,226 |
| 6 | ComprehensiveNetIncome | -8,715,990 |
| 7 | BaseVar | 13,371,855 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.37 |
| 9 | EconomicCapitalRatio | 1.96 |